25 years of experience in medical research and clinical development of therapeutics products, including a 10-year period leading clinical operations at Bayer.
Global Head of Scientific Affairs at Sirtex Technology Pty Ltd, an Australian listed oncology company, where he managed a global clinical operations budget in excess of A$20 million.
Successfully delivered Sirtex’s global pivotal studies with a combined enrolment of 1103 patients, in over 200 investigator sites in 24 countries.
Global Head of Biosimilar Development Business Group within Quintiles.
Managed clinical trials in the indications of oncology, renal medicine, Chron’s disease, multiple sclerosis, hematology and surgery.